相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。STEAP1 regulation and its influence modulating the response of LNCaP prostate cancer cells to bicalutamide, enzalutamide and apalutamide
Sandra Rocha et al.
Molecular Medicine Reports (2023)
Safety and survival of docetaxel and cabazitaxel in metastatic castration-resistant prostate cancer
Kristine Kreis et al.
BJU INTERNATIONAL (2022)
Molecular landscape of c-Myc signaling in prostate cancer: A roadmap to clinical translation
Mojdeh Amini Faskhoudi et al.
PATHOLOGY RESEARCH AND PRACTICE (2022)
Caspases and Their Substrates
Douglas R. Green
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2022)
Comprehensive Landscape of STEAP Family Members Expression in Human Cancers: Unraveling the Potential Usefulness in Clinical Practice Using Integrated Bioinformatics Analysis
Sandra M. Rocha et al.
DATA (2022)
Efficacy of cabazitaxel and the influence of clinical factors on the overall survival of patients with castration-resistant prostate cancer: A local experience of a multicenter retrospective study
Manabu Takai et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2021)
Advances in Delivery of Chemotherapeutic Agents for Cancer Treatment
Asmita Yadav et al.
AAPS PHARMSCITECH (2021)
Association between the anticancer efficacy of cabazitaxel and toll-like receptor 4 mediating signaling pathways in metastatic castration-resistant prostate cancer cells
Gamze Guney Eskiler et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2021)
Regulatory Roles of Six-Transmembrane Epithelial Antigen of the Prostate Family Members in the Occurrence and Development of Malignant Tumors
Wen-Jia Chen et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Molecular Profiling of Docetaxel-Resistant Prostate Cancer Cells Identifies Multiple Mechanisms of Therapeutic Resistance
Thiago S. Lima et al.
CANCERS (2021)
Current Perspectives on Taxanes: Focus on Their Bioactivity, Delivery and Combination Therapy
Jan Skubnik et al.
PLANTS-BASEL (2021)
Molecular Mechanism Mediating Cytotoxic Activity of Cabazitaxel in Docetaxel-resistant Human Prostate Cancer Cells
Hiromitsu Watanabe et al.
ANTICANCER RESEARCH (2021)
Prognostic significance of third-line treatment for patients with metastatic castration-resistant prostate cancer: comparative assessments between cabazitaxel and other agents
Hideaki Miyake et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2021)
Six-transmembrane epithelial antigen of the prostate 1 accelerates cell proliferation by targeting c-Myc in liver cancer cells
Kazutaka Iijima et al.
ONCOLOGY LETTERS (2021)
Inflammation mobilizes copper metabolism to promote colon tumorigenesis via an IL-17-STEAP4-XIAP axis
Yun Liao et al.
NATURE COMMUNICATIONS (2020)
CD133 suppression increases the sensitivity of prostate cancer cells to paclitaxel
Marjan Aghajani et al.
MOLECULAR BIOLOGY REPORTS (2020)
The role of taxane-based chemotherapy in the treatment of prostate cancer
Nicolai A. Huebner et al.
CURRENT OPINION IN UROLOGY (2020)
STEAP1 facilitates metastasis and epithelial-mesenchymal transition of lung adenocarcinoma via the JAK2/STAT3 signaling pathway
Shu-fen Huo et al.
BIOSCIENCE REPORTS (2020)
Six-transmembrane epithelial antigen of the prostate 1 expression promotes ovarian cancer metastasis by aiding progression of epithelial-to-mesenchymal transition
Zhi Jiao et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2020)
HMGB1 release promotes paclitaxel resistance in castration-resistant prostate cancer cells via activating c-Myc expression
Xiu Lei et al.
CELLULAR SIGNALLING (2020)
Cabazitaxel exhibits more favorable molecular changes compared to other taxanes in androgen-independent prostate cancer cells
Ozge Cevik et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2020)
A research of STEAP1 regulated gastric cancer cell proliferation, migration and invasion in vitro and in vivos
Zhe Zhang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
EIF4E regulates STEAP1 expression in peritoneal metastasis
Jun-nan Jiang et al.
JOURNAL OF CANCER (2020)
Quercetin reverses docetaxel resistance in prostate cancer via androgen receptor and PI3K/Akt signaling pathways
Xinxing Lu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
Overall and progression-free survival with cabazitaxel in metastatic castration-resistant prostate cancer in routine clinical practice: the FUJI cohort
Magali Rouyer et al.
BRITISH JOURNAL OF CANCER (2019)
FAM3B promotes progression of oesophageal carcinoma via regulating the AKT-MDM2-p53 signalling axis and the epithelial-mesenchymal transition
Song-Lin He et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Targeting STEAP1 Protein in Human Cancer: Current Trends and Future Challenges
J. Barroca-Ferreira et al.
CURRENT CANCER DRUG TARGETS (2018)
Knockdown of STEAP1 inhibits cell growth and induces apoptosis in LNCaP prostate cancer cells counteracting the effect of androgens
Ines Margarida Gomes et al.
MEDICAL ONCOLOGY (2018)
High mobility group A2 (HMGA2) promotes EMT via MAPK pathway in prostate cancer
Ohuod Hawsawi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
STEAP1 Regulates Tumorigenesis and Chemoresistance During Peritoneal Metastasis of Gastric Cancer
Yuan-Yu Wu et al.
FRONTIERS IN PHYSIOLOGY (2018)
Naringin sensitizes human prostate cancer cells to paclitaxel therapy
Suat Erdogan et al.
PROSTATE INTERNATIONAL (2018)
Combined Effects of Baicalein and Docetaxel on Apoptosis in 8505c Anaplastic Thyroid Cancer Cells via Downregulation of the ERK and Akt/mTOR Pathways
Chan Ho Park et al.
ENDOCRINOLOGY AND METABOLISM (2018)
PAQR6 expression enhancement suggests a worse prognosis in prostate cancer patients
Bin Li et al.
OPEN LIFE SCIENCES (2018)
MYC Overexpression at the Protein and mRNA Level and Cancer Outcomes among Men Treated with Radical Prostatectomy for Prostate Cancer
Andreas Pettersson et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2018)
Six-transmembrane epithelial antigens of the prostate comprise a novel inflammatory nexus in patients with pustular skin disorders
Yun Liang et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Downregulation of TRPM7 suppressed migration and invasion by regulating epithelial-mesenchymal transition in prostate cancer cells
Liang Chen et al.
MEDICAL ONCOLOGY (2017)
Molecular complexity of taxane-induced cytotoxicity in prostate cancer cells
Josef Mang et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2017)
Reactive oxygen species induction by cabazitaxel through inhibiting Sestrin-3 in castration resistant prostate cancer
Takeo Kosaka et al.
ONCOTARGET (2017)
The Different Mechanisms of Cancer Drug Resistance: A Brief Review
Behzad Mansoori et al.
ADVANCED PHARMACEUTICAL BULLETIN (2017)
Magnesium homeostasis in colon carcinoma LoVo cells sensitive or resistant to doxorubicin
Sara Castiglioni et al.
SCIENTIFIC REPORTS (2015)
Curcumin triggers apoptosis via upregulation of Bax/Bcl-2 ratio and caspase activation in SW872 human adipocytes
Lin Zhu et al.
MOLECULAR MEDICINE REPORTS (2015)
PI3K/AKT signaling pathway and cancer: an updated review
Miriam Martini et al.
ANNALS OF MEDICINE (2014)
MYC and the Control of Apoptosis
Steven B. McMahon
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
Caffeic acid phenethyl ester synergistically enhances docetaxel and paclitaxel cytotoxicity in prostate cancer cells
Mai F. Tolba et al.
IUBMB LIFE (2013)
Increase in Serum Ca2+/Mg2+ Ratio Promotes Proliferation of Prostate Cancer Cells by Activating TRPM7 Channels
Yuyang Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Modulation of mitochondrial apoptosis by PI3K inhibitors
Simone Fulda
MITOCHONDRION (2013)
Residual Prostate Cancer Cells after Docetaxel Therapy Increase the Tumorigenic Potential via Constitutive Signaling of CXCR4, ERK1/2 and c-Myc
Koji Hatano et al.
MOLECULAR CANCER RESEARCH (2013)
STEAP1 Is Associated with the Invasive and Oxidative Stress Phenotype of Ewing Tumors
Thomas G. P. Grunewald et al.
MOLECULAR CANCER RESEARCH (2012)
Mechanisms of MYC stabilization in human malignancies
Melissa R. Junttila et al.
CELL CYCLE (2008)
Monoclonal antibodies to six-transmembrane epithelial antigen of the prostate-1 inhibit intercellular communication in vitro and growth of human tumor xenografts in vivo
Pia M. Challita-Eid et al.
CANCER RESEARCH (2007)
Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities
GG He et al.
ONCOGENE (2005)